Thus, the question of IVUS versus OCT is wrong and, in fact, belies the true conundrum. Although there are clear differences between the two technologiesresolution and surface detail favoring OCT, penetration and media-to-media sizing favoring IVUS, fine details favoring OCT, the bulk of clinical data favoring IVUSbetter questions are IVUS or OCT versus angiography alone and why these technologies are so underutilized given the evidence that has been presented in both of our cases and the fact that the major determinants of optimal stent implantation can be assessed better by either IVUS or OCT than by angiography alone.
HCG is a highly beneficial hormone in fertility stimulation and in the treatment of low testosterone. In fact, it is rapidly becoming an integral part of many low testosterone treatment plans. For the anabolic steroid user, the performance enhancing athlete, HCG can be beneficial but it can also be damaging. Many get very carried away with on cycle use and lead themselves to an early low testosterone condition. Granted, most men will benefit from testosterone therapy at some point in their life regardless, but many steroid users end up requiring sooner and often due to improper HCG use. The hormone can be beneficial but use must be kept moderate and monitored.
Then we’re left with PCT Clomid use. Standard PCT Clomid doses will normally start at 100-150mg per day for 1-2 weeks. From here the dose will drop to 50-100mg per day for 1-2 weeks and finish with 1-2 weeks at 50mg per day. Total Clomid therapy should last 4-6 weeks, so dosing should be based and considered on that total schedule. Most will also be far more successful in their PCT recovery by including Nolvadex and HCG. Timing is also important when planning your Clomid PCT use, and this timing factor will vary depending on the inclusion of HCG: